Scbio

Developer of small molecule immuno-oncology drugs

placeYuseong, Daejeon, South Korea calendar_todayFounded 2021 groups23 employees language sc-bio.co.kr

Innovation

4 patent families (1 granted) — focus: Human necessities; filing pace active.

Coming soon